IMC Announces Results of its Annual General and Special Meeting of Shareholders
IM Cannabis Corp. (CSE:IMCC, NASDAQ:IMCC) announced the results from its annual general and special meeting held on July 28, 2021. A total of 37,108,584 shares were voted, representing 65.03% of outstanding shares. Shareholders approved all resolutions, including the appointment of directors and the re-appointment of auditors. Notable voting results included strong support for nominees Oren Shuster and Marc Lustig, receiving 96.19% of votes for their election. The company continues to strengthen its operations in Israel, Germany, and Canada.
- Strong shareholder support with 65.03% participation in voting.
- All resolutions approved, ensuring stability in management and operations.
- Election of key directors like Oren Shuster with 96.19% approval.
- None.
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 3, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the voting results from its annual general and special meeting of shareholders held on Wednesday July 28, 2021 (the "Meeting").
A total of 37,108,584 common shares of the Company were voted at the Meeting, representing
Detailed results of the votes on the election of directors are as follows:
Director Nominee | Votes For | % | Votes Withheld | % |
Oren Shuster | 26,398,764 | 96.19 | 1,045,449 | 3.81 |
Marc Lustig | 26,398,755 | 96.19 | 1,045,458 | 3.81 |
Vivian Bercovici | 27,440,895 | 99.99 | 3,318 | 0.01 |
Haleli Barath | 27,441,054 | 99.99 | 3,159 | 0.01 |
Brian Schinderle | 27,440,784 | 99.99 | 3,429 | 0.01 |
For further detailed voting results on the Meeting, please refer to the Company's Report of Voting Results filed on SEDAR at www.sedar.com.
About IM Cannabis Corp.
IMC is an MCO in the medical and adult-use recreational cannabis sector, headquartered in Israel and with operations In Israel, Germany and Canada. Over the past decade, the Company believes that the IMC brand has become synonymous with quality and consistency in the Israeli medical cannabis market. The Company has also expanded its business to offer intellectual property-related services to the medical cannabis industry.
In Europe, IMC operates through Adjupharm GmbH, a German-based subsidiary and EU-GMP-certified medical cannabis distributor. IMC's European presence is augmented by strategic alliances with various pan-European EU-GMP cultivators and distributors to capitalize on the increased demand for medical cannabis products in Europe and bring the IMC brand and its product portfolio to European patients.
In Canada, IMC operates through Trichome d/b/a JWC. JWC is a licensed producer located in Kitchener, Ontario, selling cannabis flower, pre-rolls, hash and kief in the Canadian recreational cannabis market under the JWC and WAGNERS brands. JWC operates with high standards for providing clean, consistent, aeroponically-grown premium cannabis products to medical patients and the adult-use market throughout Canada and the world. IMC also operates MYM Nutraceuticals Inc. and its licensed producer subsidiary, Highland Grow Inc.
CONTACTS:
Oren Shuster
CEO, IM Cannabis Corp.
+972-77-3603504
info@imcannabis.com
Caitlin Kasunich
Media Relations - U.S.
+1 212-896-1241
ckasunich@kcsa.com
Gal Wilder
Media Relations - Canada
+1 416-602-4092
gwilder@cohnwolfe.ca
Elizabeth Barker
Investor Relations
+1 212-896-1203
ebarker@kcsa.com
SOURCE: IM Cannabis Corp.
View source version on accesswire.com:
https://www.accesswire.com/658135/IMC-Announces-Results-of-its-Annual-General-and-Special-Meeting-of-Shareholders
FAQ
What were the voting results for IM Cannabis Corp. at the July 28, 2021 meeting?
How much shareholder participation was recorded at the IM Cannabis Corp. meeting?
Who were re-elected as directors at IM Cannabis Corp. on July 28, 2021?